Navigation Links
Molecular Biology Enzymes, Kits & Reagents Market worth $5,420.63 Million by 2018

DALLAS, August 5, 2014 /PRNewswire/ --

According to research report "Molecular Biology Enzymes, Kits, & Reagents Market by Application (Cloning, Epigenetics, PCR, Restriction Digestion, Sequencing), Product (Ligase, Phosphatase, Polymerase, Protease, Restriction Endonuclease, Reverse Transcriptase) - Global Forecast to 2018" published by MarketsandMarkets, report provides a detailed overview of the major drivers, restraints, challenges, opportunities, current market trends, and strategies impacting the global molecular biology enzymes, kits & reagents market along with the estimates and forecasts of the revenue and market share analysis.

Browse 133 market data tables, 52 figures spread through 265 pages and in-depth TOC on "Molecular Biology Enzymes, Kits, & Reagents Market"

Early buyers will receive 10% customization on this report. 

The global Molecular Biology Enzymes, Kits & Reagents Market was valued at $2,847.63 Million in 2013. This market is expected to grow at a CAGR of 13.74% to reach $5,420.63 Million in 2018.

The Molecular Biology Enzymes, Kits & Reagents Market is segmented on the basis of applications, end users and products. By application, the market is divided into cloning, epigenetics, PCR (Polymerase Chain Reaction), restriction digestion, sequencing, and other applications. Of these, the PCR applications segment accounted for the largest share of the molecular biology enzymes, kits and reagents market in 2013. The end-user segments included in this report are academic research institutes, hospital and diagnostic centers, pharmaceutical and biotech companies, and other end users. By products, the market is segmented into enzymes, and kits and reagents.

The enzymes product segment consists of seven sub-segments, namely, ligases, phosphatases, polymerases, proteases and proteinases, restriction endonucleases, reverse transcriptase, and other enzymes. Of these, the polymerase enzyme product sub-segment had the largest share of the molecular biology enzymes market in 2013, and is poised to grow at the highest CAGR between 2013 and 2018. The kits and reagents segment is divided into cloning and mutagenesis, nucleic acid analysis, PCR, sequencing, and other kits and reagents.

The geographic segments included in this report are Asia, Europe, North America, and Rest of the World. The Asian segment is further divided into the regional segments of China, India, Japan, and Rest of Asia. Europe is divided into the regional segments of France, Germany, Italy, Spain, the U.K., and Rest of Europe. North America includes Canada, and the U.S. The Rest of the World geographic segment encompasses Latin America, Middle East and Africa, and the Pacific region.

Increases in R&D expenditure by pharmaceutical and biotech companies and investments in life science and genomics research will be the two most important growth drivers for this market in the forecast period (2013-2018). For instance, the Chinese government increased its basic research investment by 26% from 2011 to 2012 and put more than $300 billion into biotechnology from 2012 to 2017. Similarly, in 2011, Europe increased investment in research to $108 billion in 2014-2020. This will increase the demand for products offered by the Molecular Biology Enzymes Market. Moreover, the increase in the aged population, at risk of contracting chronic and infectious diseases, will further boost the need for research into ailments such as cancer and heart diseases, further increasing the demand for molecular biology enzymes, kits and reagents products.

Inquiry before buying @ 

The major players in the Molecular Biology Enzymes, Kits and Reagents Market include Affymetrix, Inc. (U.S.), Agilent Technologies, Inc. (U.S.), Enzymatics, Inc. (U.S.), Illumina, Inc. (U.S.), New England Biolabs, Inc. (U.S.), QIAGEN, N.V. (Netherlands), Roche, Ltd. (Switzerland), Sigma-Aldrich Co. LLC (U.S), Takara Bio, Inc. (Japan), and Thermo Fisher Scientific, Inc. (U.S.).

Browse related reports 

Nucleic Acid Isolation and Purification Market by Technology (Column based, Reagent based, Magnetic bead based), Consumables & Instruments, Application (Plasmid DNA isolation, MIRNA isolation, Total RNA isolation) & by End Users - Global Forecasts to 2018

Molecular Diagnostics Market by Application (Infectious Disease, Oncology, Genetics, Microbiology), Technology (PCR, INAAT, DNA Sequencing), End User (Hospital, Laboratories), Product (Instruments, Reagent, Service, Software) - Global Forecasts to 2018

About MarketsandMarkets  

MarketsandMarkets is a global market research and consulting company based in the U.S. We publish strategically analyzed market research reports and serve as a business intelligence partner to Fortune 500 companies across the world.

MarketsandMarkets also provides multi-client reports, company profiles, databases, and custom research services. MarketsandMarkets covers thirteen industry verticals, including advanced materials, automotive and transportation, banking and financial services, biotechnology, chemicals, consumer goods, energy and power, food and beverages, industrial automation, medical devices, pharmaceuticals, healthcare IT semiconductor and electronics, and telecommunications and IT.

We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository.

Mr. Rohan
North - Dominion Plaza,
17304, Preston Road,
Suite 800, Dallas, TX 75252
Tel: +1-888-600-6441

Visit MarketsandMarkets Blog

SOURCE MarketsandMarkets
Copyright©2014 PR Newswire.
All rights reserved

Related biology technology :

1. A nano car with molecular 4-wheel drive
2. Amsterdam Molecular Therapeutics Provides Business Update for the Third Quarter 2011
3. Chemists become molecular sculptors, synthesizing tiny, molecular traps
4. Why Medicare Carrier Proposes Major Changes in the Handling of Code Stacked Molecular Test Claims is Topic of December 20 Audio Conference
5. Amsterdam Molecular Therapeutics Announces Negative Equity Position
6. Quanterix Develops Microfluidic Consumable That Will Enable Next Generation Molecular Diagnostic Systems based on Single Molecule Array Technology
7. The art of molecular carpet-weaving
8. Amsterdam Molecular Therapeutics Announces € 2.5 Million Equity Raise
9. Amsterdam Molecular Therapeutics Receives US Orphan Designation for Hemophilia B Gene Therapy
10. Life Technologies Partners With DaAn Gene to Develop and Commercialize Molecular Diagnostic Assays in China
11. Accelerate Brain Cancer Cure and Exosome Diagnostics Collaborate to Advance Clinical Studies of Exosome Biofluid Molecular Diagnostics Technology in Brain Cancer
Post Your Comments:
(Date:11/27/2015)... ... 27, 2015 , ... Pittcon is pleased to announce the ... in symposia, oral sessions, workshops, awards, and posters. The core of the ... such as, but not limited to, biotechnology, biomedical, drug discovery, environmental, food science, ...
(Date:11/26/2015)... CHESHAM , England , November 26, ... Lightpoint Medical, an innovative medical device company specializing in ... Euro grant from the European Commission as part of the ... enabling the company to carry out a large-scale clinical trial ... -->      (Logo: , ...
(Date:11/25/2015)... -- 2 nouvelles études permettent d , ... entre les souches bactériennes retrouvées dans la plaque ... . Ces recherches  ouvrent une nouvelle voie ... efficace de l,un des problèmes de santé les ...    --> 2 nouvelles études permettent d ...
(Date:11/25/2015)... Nov. 25, 2015  Neurocrine Biosciences, Inc. (Nasdaq: ... President and CEO of Neurocrine Biosciences, will be presenting ... New York . ... website approximately 5 minutes prior to the presentation to ... the presentation will be available on the website approximately ...
Breaking Biology Technology:
(Date:11/18/2015)... , Nov. 18, 2015  As new scientific ... children, doctors and other healthcare providers face challenges in ... families and patients. In addition, as more children continue ... a patient,s adulthood and old age. John ... The Children,s Hospital of Philadelphia (CHOP) . ...
(Date:11/17/2015)... , November 17, 2015 Paris ... 2015.   --> Paris from 17 ... DERMALOG, the biometrics innovation leader, has invented the first ... fingerprints on the same scanning surface. Until now two different ... Now one scanner can capture both on the same ...
(Date:11/17/2015)... -- Vigilant Solutions announces today that Mr. Dick W. ... --> --> Mr. Boyce ... at TPG Capital, one of the largest global investment ... revenue.  He founded and led TPG,s Operating Group, which ... 1997 to 2013.  In his first role, he served ...
Breaking Biology News(10 mins):